Pharyngitis/Tonsillitis, Acute Bacterial Otitis Media, Haemophilus influenzae (including beta-lactamase–producing strains), Moraxella catarrhalis (including beta-lactamase–producing strains), Acute Bacterial Maxillary Sinusitis. Acute Bacterial Exacerbations of Chronic Bronchitis and Secondary Bacterial Infections of Acute Bronchitis, Uncomplicated Skin and Skin-Structure Infections, Uncomplicated Urinary Tract Infections, Uncomplicated Gonorrhea, Early Lyme disease (erythema migrans).

 Adolescents and Adults (13 years and older)
 Pharyngitis/tonsillitis 250 mg b.i.d. 
 Acute bacterial maxillary sinusitis 250 mg b.i.d. 
 Acute bacterial exacerbations of chronic bronchitis 250 or 500 mg b.i.d. 
 Secondary bacterial infections of acute bronchitis 250 or 500 mg b.i.d. 
 Uncomplicated skin and skin-structure infections 250 or 500 mg b.i.d.
 Uncomplicated urinary tract infections 250 mg b.i.d. 
 Uncomplicated gonorrhea 1,000 mg once single dose
 Early Lyme disease 500 mg b.i.d.

 Patients with known hypersensitivity to cephalosporin antibiotics.

Anaphylactic reaction to penicillin. Pseudomembranous colitis Over growth of non susceptible organisms.
Paediatrics: Not safe in children below 3 months.
Pregnancy: Use with caution.
Lactation: Use with caution.

 Skin rashes, Eosinophilia and transient increase of hepatic enzymes.

Synergy with aminoglycosides.

4X10